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Dendritic cell (DC) differentiation is regulated by
stroma via a network of soluble and cell-bound
factors. Notch is one of the major elements of this
network. Its role in DC differentiation, however, is
controversial. Here, we demonstrate that activation
of Notch signaling in hematopoietic progenitor cells
(HPCs) promoted differentiation of conventional
DCs via activation of the canonical Wingless (Wnt)
pathway. Inhibition of the Wnt pathway abrogated
the effect of Notch on DC differentiation. The fact
that activation of the Wnt pathway in Notch-1-defi-
cient embryonic stem cells restored DC differentia-
tion indicates that Wnt signaling is downstream of
the Notch pathway in regulating DC differentiation.
Notch signaling activated the Wnt pathway in HPCs
via expression of multiple members of the Frizzled
family of Wnt receptors, which was directly regulated
by the CSL (RPB-Jk) transcription factor. Thus, these
data suggest a model of DC differentiation via coop-
eration between Wnt and Notch pathways.
INTRODUCTION
Dendritic cells (DCs) are antigen-presenting cells with critically
important functions in innate and adaptive immunity. DCdifferen-
tiation from hematopoietic progenitor cells (HPCs) is controlled
by bone marrow stroma (BMS) via a complex network of soluble
cytokines and cell-bound molecules. Recent studies have impli-
cated the Notch pathway in differentiation and function of these
cells (reviewed in Cheng and Gabrilovich, 2008). According to
the conventional model, Notch signaling is initiated upon the
binding of the extracellular domain of HPC-expressed Notch re-
ceptors toNotch ligands: Jagged andDelta. Proteolytic cleavage
within the transmembrane subunit of theNotch receptor results in
translocation of the intracellular domain of Notch (ICN) to the
nucleus where it interacts with the transcriptional repressor
CSL (RBP-Jk). Binding of ICN displaces corepressor complexes,
thereby activating transcription by promoters with CSL binding
elements (Allman et al., 2002; Artavanis-Tsakonas et al., 1999;
Curry et al., 2006; Osborne and Minter, 2007).
The effect of Notch on DC differentiation is highly contro-
versial. A number of groups have described a direct role of
Notch in promoting DC differentiation. Expression of Delta-1 inconjunction with GM-CSF induced differentiation of bone
marrow cells to DCs (Mizutani et al., 2000). Delta-1 promoted
DC and Langerhans cell differentiation from peripheral blood
monocyte precursors (Hoshino et al., 2005; Ohishi et al., 2001).
Consistent with these observations, differentiation of DC was
impaired in Notch-1 antisense mice (Cheng et al., 2001). These
findings were further confirmed in an experimental model of
DC differentiation of Notch1/ embryonic stem cells (ESCs)
(Cheng et al., 2003). Conditional deletion of RBP- Jk in BM cells
resulted in a substantial reduction of the presence of conven-
tional CD8- DCs in the marginal zone of spleen of the gene-defi-
cient mice (Caton et al., 2007). The increase in PU.1 RNA expres-
sion (Schroeder et al., 2003) and IL-4 production (Amsen et al.,
2004) by activated Notch-1 may help to explain the shift in DC
differentiation induced by Delta-1 and was consistent with the
report that Notch-induced generation of interstitial-type DCs
was associated with PU.1 upregulation (Heinz et al., 2006).
A number of studies, however, have described different role of
Notch signaling in DC differentiation. In conditional Notch1/
mice, the number of thymic DCs, conventional DCs, and Langer-
hans cells were normal (Radtke et al., 2000). Inhibition of Notch
signaling with g-secretase inhibitor shifted differentiation into
non-T cells including monocyte and DCs (De Smedt et al.,
2005). Deletion of Notch in T cell progenitors supported their
differentiation to DCs (Feyerabend et al., 2009). Notch signaling
was also found to play a prominent role in inhibitingmacrophage,
DC, and NK cell differentiation (Garcia-Peydro et al., 2006).
Similar contradictory data exists in respect to the effect of
Notch signaling on plasmacytoid DCs (pDCs). Oliver et al. re-
ported that Notch signaling via Delta-1 promoted differentiation
of pDCs (Olivier et al., 2006), whereas in a different study, stromal
cells expressing Delta-1 blocked pDC development (Dontje
et al., 2006). Inactivation of Notch-1 (Ferrero et al., 2002; Radtke
et al., 2000) did not affect the development of pDCs. In contrast,
RBP-J-deficient mice have shown an increased number of pDCs
(Caton et al., 2007), suggesting that Notch signaling may play an
inhibitory role in the development of these cells.
The Wingless (Wnt) signaling pathway is involved at different
stages of development including the self-renewal of HSC and
the HPC cell fate decision (Staal et al., 2008). HPCs respond to
Wnt proteins secreted either by surrounding stroma or by
HPCs themselves in a paracrine or autocrine fashion. Interaction
of Wnt with receptors activates several pathways. Canonical
Wnt signaling is centered on b-catenin. In the absence of Wnt
ligand binding to its receptor complex, b-catenin is targeted for
degradation by the proteasome through the action of the
destruction complex involving adenomatous polyposis coli,Immunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc. 845
Figure 1. Delta-1 Activates Wnt Signaling in HPCs
(A–E) Enriched HPCs from bone marrow were incubated on amonolayer of NIH 3T3 fibroblasts expressing either Delta-1 or control EF vectors in CCM containing
20 ng/mL GM-CSF.
(A) Expression of Frizzled gene family (Fzd) in HPCs was evaluated in triplicates by qRT-PCR after an 18 hr culture. Relative gene expression was calculated by
normalization to internal control (cyclophilin). Mean ± SE from five performed experiments are shown. The asterisks mark statistically significant differences
(p < 0.05) between EF and Delta-1 groups calculated with a two-sided t test.
(B) Selected Frizzled members were further evaluated by immunoblotting with indicated antibodies after 3 days of culture. Relative intensity of bands normalized
to b-actin is shown in the bottom panel.
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axis inhibition protein 1, the serine-threonine kinases casein
kinase 1, and glycogen synthase kinase 3b (GSK3b). At the cell
membrane, Wnt binds to Frizzled receptors and coreceptors
such as low-density lipoprotein receptor-related proteins
(LRP). This results in stabilization of b-catenin. Soluble b-catenin
then translocates to the nuclei and displaces groucho-related
repressor from T cell factor (TCF)-lymphoid enhancer factor
(LEF) transcription factor. TCF-LEF is then able to regulate
expression of target genes (Katoh and Katoh, 2007; Mikels and
Nusse, 2006; Reya and Clevers, 2005).
There is now emerging evidence of crosstalk between Notch
and Wnt pathways. Wnt signaling may regulate Notch via regu-
lated transcription of the Notch ligand Delta-1 in the presomitic
mesoderm (Hofmann et al., 2004). Inhibition of Notch signaling
can lead to accelerated differentiation of HSCs in vitro and intact
Notch signaling was required for Wnt-mediated maintenance
of undifferentiated HSCs (Duncan et al., 2005). Regulation of
Notch signaling by the Wnt pathway plays a critical role in differ-
entiation of precursors along T or NK cell differentiation path-
ways (Aoyama et al., 2007).
Very little is known about the potential role of Wnt signaling in
DC differentiation. One study has shown that in vitro differentia-
tion of human monocytes into either DCs or macrophages was
associated withWnt5A expression (Lehtonen et al., 2007). Matu-
ration of DCs under steady-state conditions was caused by
alterations in E-cadherin-mediated adhesion. These events
were triggered at least in part by activation of the b-catenin
pathway (Jiang et al., 2007).
In this study, we address the question of how Notch signaling
can regulate DC differentiation and report observations that DC
differentiation requires close cooperation between Notch and
Wnt pathways.
RESULTS
Delta-1 ActivatesWnt Signaling inHPCs byUpregulation
of Frizzled Family of Wnt Receptors
First, we evaluated the effect of Notch ligand Delta-1 on the Friz-
zled gene family (Fzd) of Wnt receptors in HPCs by using qRT-
PCR. Enriched bone marrow HPCs were incubated for 18 hr
on a monolayer of NIH 3T3 fibroblasts expressing either Delta-1
or corresponding control vector EF. Delta-1 fibroblasts induced
significant (p < 0.05) upregulation of eight different Fzd genes in
Immunity
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members of the Fzd family were evaluated by immunoblotting.
Consistent with the results of gene expression, Delta-1 cells
upregulated Fzd6 and Fzd10 but did not affect Fzd7 (Figure 1B).
We asked whether Delta-1-inducible upregulation of Wnt recep-
tors would result in activation of the Wnt pathway. To evaluate
the degree of Wnt signaling, we transfected HPCs with TCF-
LEF-luciferase reporter construct and cultured them on Delta-1
cells. Forty eight hours’ incubation of HPCs on Delta-1 fibro-
blasts resulted in more than a 3-fold increase in the activity of
this transcription factor (Figure 1C). The effect on Wnt signaling
was confirmed further by evaluation of the expression of several
Wnt-targeted genes: Wisp1, Wisp2, and Axin2. Delta-1 cells
significantly (p < 0.05) upregulated these genes but did not affect
mRNA for Hcf1a, which is not transcriptionally regulated by Wnt
signaling (Figure 1D). Delta-1 fibroblasts also increased the level
of b-catenin in HPCs (Figure 1E).
Because activation of the Wnt pathway may depend on the
amount of ligand available, we compared the expression of
different Wnt family members in control and Delta-1 cells by
using qRT-PCR. Both cell lines had no detectable Wnt3a and
showed similar expression of Wnt1, Wnt10b, Wnt2, and Wnt4.
Expression of Wnt5 was significantly (p < 0.05) lower in Delta-
1-expressing cells than in control fibroblasts (Figure S1A avail-
able online), suggesting that variations in the amount of Wnt
are not directly responsible for the effect of Delta-1 fibroblasts
on HPCs. Activation of the Notch pathway by Delta-1 in HPCs
also did not change the expression of Wnt ligands (Figures
S1B and S1C). To exclude the possibility that other members
of theWnt family or factors released by fibroblasts may influence
these results, we used an experimental system in which Notch
signaling was activated by Delta-1 immobilized on plastic,
thereby removing the involvement of stromal cells. HPCs were
cultured for 18 hr in wells coated with ether control IgG or
Delta-1-IgG. An equal amount of recombinant Wnt3a was added
to all cultures. Delta-1 substantially activated the Notch pathway
(p < 0.01), determined by activation of CBF-1 transcription factor
(Figure 1F) and by the increased expression of the Notch-tar-
geted gene Hes5 (Figure 1G). Delta-1 did not affect the expres-
sion of Wnt ligands in HPCs (Figures S1B and S1C) but induced
dramatic upregulation of the expression of Fzd10 as well asWnt-
targeted genes Axin2, Wisp1, and Wisp2 (Figure 1G). The effect
of Delta-1 on Wnt receptors was confirmed by the analysis of(C) HPCs were transfected with TCF-LEF reporter plasmid and then cultured on fibroblast cells for 48 hr. Reporter activity was measured with a dual-luciferase
reporter assay. The asterisk marks a statistically significant difference from controls (p < 0.05). Mean ± SE of three performed experiments are shown.
(D) Expression of Wnt target genes in HPCs were measured in triplicates by qRT-PCR after an 18 hr culture. Cumulative results of four experiments are shown.
(E). Expression of b-catenin was measured by immunoblotting after 3 days’ culture. HPCs were transferred onto new fibroblasts after 2 days. Relative intensity of
bands normalized to b-actin is shown in the bottom panel.
(F–I) Enriched HPCs were cultured on plates coated with immobilized Delta-1 protein.
(F) Enriched HPCs were transfected with CBF-1-luciferase reporter construct and cultured in wells of a 24-well plate coated with 7.5 mg/ml Delta1-IgG or control
IgG protein in the presence of 100 ng/ml recombinantWnt3A. Reporter activity wasmeasuredwith a dual-luciferase reporter assay. The asterisk indicates a statis-
tically significant difference from controls (p < 0.05). Cumulative results of three performed experiments are shown.
(G) Enriched HPCs were cultured in wells of a 24-well plate coated with Delta1-IgG or control IgG protein in the presence of 100 ng/ml recombinant Wnt3A.
Expression of Fzd genes and Wnt-targeted genes was evaluated with qRT-PCR after a 24 hr culture. Cumulative results of three performed experiments are
shown.
(H) Selected Frizzled proteins were further evaluated by immunoblotting with specific antibodies after 3 days of culture. Relative intensity of bands normalized to
b-actin is shown in the bottom panel.
(I) HPCs were transfected with TCF-LEF reporter plasmid before culture on a ligand-coated plate. Reporter activity was measured 48 hr later. Mean ± SE from
three performed experiments are shown. The asterisk indicates a statistically significant difference from controls (p < 0.05).
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increased the transcriptional activity of TCF-LEF in HPCs
(Figure 1I). These results were very similar to the data obtained
from experiments with Delta-1 fibroblasts and indicated that
Notch ligand induced upregulation of Wnt receptors and
signaling in HPCs.
Wnt Signaling Promotes DC Differentiation
We then went on to explore how changes in Wnt signaling may
affect DC differentiation. We first investigated the activity of the
Wnt pathway during a 6 day period of DC differentiation from
HPCs in the presence of GM-CSF with or without IL-4. DC differ-
entiation was associated with dramatic b-catenin upregulation
(Figure 2A), which was observed within 24 hr after start of the
culture (Figure S2). This was associated with activation of the
TCF-LEF transcription factor (Figure 2B) and the expression of
Wnt-targeted genes (Figure 2C).
Next, we asked whether activation of the Wnt pathway could
regulate DC differentiation. At the start of a 5 day HPC culture
in the presence of GM-CSF, the Wnt pathway was stimulated
with either a specific ligand (Wnt3a) or with the selective
GSK3b inhibitor SB216763. Activation of the Wnt pathway re-
sulted in a significant (p < 0.05) increase in the proportion of
CD11c+ DCs (Figure 2D). All CD11c+ DCs generated in Wnt-
activating conditions expressed MHC class II or CD86 mole-
cules, indicating their fully mature state. Activation of the Wnt
pathway did not affect the proportion of F4/80+Gr-1 macro-
phages and substantially decreased the proportion of Gr-1+
CD11b+ immature myeloid cells (IMCs) (Figure 2D). Stimulation
of allogeneic T cells is a hallmark of DC activity. Cells differenti-
ated in the presence of SB216763 were much more potent
stimulators of allogeneic T cell proliferation than control cells
(Figure 2E).
To test the effect of the Wnt pathway on DC activation, we
generated DC cells from enriched HPCs by using GM-CSF and
IL-4 and then cultured them for 24 hr with SB216763 or lipopoly-
saccharide (LPS). Activation of the Wnt pathway resulted in
a dramatic upregulation of MHC class II and costimulatory mole-
cules on DCs as well as a significant increase in their ability to
stimulate allogeneic T cells. These effects were comparable or
even stronger than those of LPS (Figure S3).
DCs generated in the presence of GM-CSF are CD11c+
CD11b+ conventional (myeloid) DCs. To evaluate the effect
of the Wnt pathway on differentiation of plasmacytoid DCs
(pDC), we cultured bone marrow cells with Flt3L for 10 days
with Wnt3a or SB216763. As was the case during DC differenti-
ation in the presence of GM-CSF, activation of Wnt signaling
during FLT3L-induced DC differentiation resulted in a significant
(p < 0.05) increase in the proportion of conventional CD11c+
CD11b+B220DCs. In striking contrast, the presence of CD11c+
CD11bB220+ pDCs was dramatically reduced (Figure 2F).
To clarify the effect of the Wnt pathway on macrophage
differentiation, we cultured enriched HPCs for 6 days with
M-CSF. SB216763 was added at the start of the culture. Activa-
tion of the Wnt pathway did not affect the proportion of F4/
80+CD11b+Gr-1 macrophages generated from HPCs (Fig-
ure S4). Taken together, these results indicate that activation
of Wnt pathway in HPCs promoted differentiation of conven-
tional DCs.848 Immunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc.Canonical and Noncanonical Wnt Pathways Have
Opposite Effect on DC Differentiation
We investigated a possible role of the noncanonicalWnt pathway
in DC differentiation. Wnt5a is a main activator of this pathway.
Enriched HPCs were cultured with GM-CSF with or without
500 ng/mlWnt5a for 5 days, and the phenotype of cells was eval-
uated. In contrast toWnt3a,Wnt5a decreasedDCdifferentiation,
which manifested in a decreased proportion of CD11c+ cells
(Figure 3A) and a lower ability of DCs generated in the presence
of Wnt5a to stimulate allogeneic T cells (Figure 3B).
Experiments described above were performed with enriched
HPCs. We asked whether Wnt signaling affects early stages of
myeloid cell differentiation. To address this question, we sorted
Linc-kit+Sca-1+CD34 HSC or Linc-kit+Sca-1CD34+ com-
mon myeloid progenitor (CMP) cells from bone marrow of naive
mice. Cells were cultured in the presence of SB216763, Wnt3a,
or Wnt5a in myeloid long-term culture medium with a cocktail of
cytokines for 5 days and then cultured for 5 days in RPMI-1640
medium supplemented with GM-CSF. Activation of the Wnt
pathway with SB216763 or Wnt3a promoted DC differentiation,
whereasWnt5a inhibited it (Figure S5).We askedwhether activa-
tion of Wnt signaling may also affect cells at later stages of
myeloid differentiation. Gr-1+CD11b+ from spleens of tumor-
bearing mice consist of precursors of myeloid cells at different
stages of differentiation (Gabrilovich, 2004). We isolated these
cells from EL-4 tumor-bearing mouse spleens and cultured
them for 5 days with GM-CSF in either medium alone or in the
presence of Wnt3a or SB216763. Activation of the Wnt pathway
resulted in significant (p < 0.05) increase in the proportion of DCs
and decreased presence of IMC (Figure S6). Thus, it appears that
two pathways of Wnt signaling may have opposite effect on DC
differentiation. Activation of canonical pathway promoted DC
differentiation, whereas activation of noncanonical pathway in-
hibited it.
b-Catenin Is Required for DC Differentiation
To evaluate the role of the canonical Wnt pathway in DC differen-
tiation, we regulated the amount of b-catenin in HPCs by using
two GFP-expressing vectors: b-catenin shRNA to block the
expression of b-catenin (Figure 3C), and a vector containing
mutant b-catenin, which is resistant to ubiquitination and degra-
dation and thus induces activation of the Wnt pathway (Jiang
et al., 2007). As a control we used aGFP-only-expressing vector.
HPCs were transfected with these vectors (Figure S7) and
cultured for 6 days with GM-CSF. The proportion of DCs was
calculated among GFP-positive cells. Constitutively active
b-catenin did not affect the total number of cells generated
fromHPCs (data not shown) but significantly (p < 0.05) increased
the proportion of CD11c+ DCs as well as mature CD11c+IAb+ or
CD86+ DCs. Inhibition of b-catenin resulted in downregulation of
DC differentiation (Figure 3D). The opposite effect was seen in
the proportion of Gr-1+CD11b+ IMC. Decreased b-catenin levels
resulted in an increased production of IMC, whereas upregula-
tion of b-catenin led to decreased presence of IMC (Figure 3D).
No effect on macrophage differentiation was observed (data
not shown).
To verify the effect of the canonical Wnt pathway on DC differ-
entiation, we used an experimental system with a conditional
deletion of b-catenin. Linc-kit+ myeloid progenitor cells were
Immunity
Notch, Wnt, and Dendritic Cell DifferentiationFigure 2. Effect of Wnt Signaling on DC Differentiation
(A–C) Enriched HPCs were cultured in CCM with 20 ng/ml GM-CSF with or without 10 ng/ml IL-4. Cells were collected at the indicated time points.
(A) Accumulation of b-catenin was measured by immunoblotting.
(B) HPCs were transfected with TCF-LEF reporter construct on days 0, 1, 3, and 6 after the start of the culture, and luciferase activity was measured 24 hr after
transfection.
(C) Expression of Wnt-targeted genes was measured at different time points with qRT-PCR.
(D) HPCs were cultured with 20 ng/ml GM-CSF for 5 days. Recombinant Wnt3a (100 ng/ml) or SB216763 (10 nM) were added at the start of the cultures. The top
panel shows a typical example of one experiment. In the bottom panel, cumulative results of three performed experiments are shown.
(E) Allogeneic MLR. Cells from experiments in (D) were cocultured with T cells isolated from allogeneic BALB/c mice for 4 days in different ratios. Cell proliferation
was measured in triplicate by [3H]-thymidine uptake. Values are the mean ± SE.
(F) Bone marrow cells were cultured with 100 ng/ml FLT3-ligand for 10 days with Wnt3a or SB216763. The left histograms show a typical example of one exper-
iment. The graph on the right contains cumulative results of three performed experiments are shown.
Immunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc. 849
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(A) Enriched HPCs were cultured with GM-CSF with or without 500 ng/ml Wnt5a recombinant protein for 5 days and the phenotype of cells was evaluated by flow
cytometry. The left panel shows a typical example of one experiment. In the right panel, cumulative results of three performed experiments are shown.
(B) Allogeneic MLR. Cells from experiments in (A) were cocultured with T cells isolated from allogeneic BALB/c mice for 4 days at different ratios. Cell proliferation
was measured in triplicate by [3H]-thymidine uptake. Values are the mean ± SE.
(C) NIH 3T3 cells were transfected with control vector or b-catenin shRNA.Whole-cell lysates were prepared 72 hr after transfection and proteins were analyzed in
immunoblotting.
(D) Enriched HPCs were transfected with GFP, b-catenin-GFP, or b-catenin-shRNA-GFP vectors. Cells were cultured in CCM with 20 ng/ml GM-CSF for 5 days
and evaluated by flow cytometry. CD45+GFP+ cells were gated for further analysis. The left histograms show a typical example of one experiment. The graphs on
the right are cumulative results (mean ± SE) of three performed experiments.
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mice. Cells were then infected with retroviruses containing either
a Cre construct or control retrovirus and cultured with cocktail of
cytokines for generation of mature myeloid cells. The b-catenin
in transduced cells was evaluated 5 days after infection with
qRT-PCR and immunoblotting. As shown in Figure 3E, infection
of floxed b-catenin cells with Cre retrovirus substantially reduced
the expression of b-catenin. The proportion of DCs generated
from floxed b-catenin myeloid progenitors infected with Cre-
retrovirus was substantially (p < 0.05) lower than that generated
from floxed b-catenin cells infected with control retrovirus or
wild-type cells infected with either retroviruses (Figure 3F). The
ability of these cells to stimulate allogeneic T cells was also
reduced (Figure 3G).
Next, 2 3104 floxed b-catenin (CD45.2+) myeloid progenitor
cells infected with control or Cre retroviruses were transferred
into lethally irradiated congenic (CD45.1+) mice together with
106 syngenic (CD45.1+) bone marrow cells. Cells were evaluated
in spleens 3 weeks later. The proportion of DCs among the
CD45.2+ population in mice transfused with myeloid cells in-
fected with Cre virus was substantially lower than that in mice
transfused with myeloid progenitors infected with the control
virus (Figure 3H). In contrast, the proportion of Gr-1+CD11b+
IMC was higher in CD45.2+ cells that were infected with Cre-
retrovirus than in cells infected with control virus (Figure 3H). No
differences in theproportionofDCsor IMCwereobservedamong
CD45.1+ cells that were not infected with virus (data not shown).
We also investigated the effect of Wnt signaling on the differ-
entiation of human DCs. CD34+ progenitor cells were cultured
in the presence of GM-CSF and SCF for 6 days with the Wnt
inhibitory factor-1 (Wif-1) or the Wnt activator SB216763. We
specifically avoided using IL-4 in the culture medium to prevent
selection of DCs during differentiation. Presence of Wif-1
decreased the proportion of Lin- HLA-DR+ DCs from 31.1% to
22.7%, whereas SB216763 increased the proportion of DCs to
52.8% (Figure S8A). Cells generated in the presence of Wif-1
had substantially reduced ability to stimulate allogeneic T cells.
In contrast, cells generated in the presence of SB216763 had
a greater ability to stimulate allogeneic T cells (Figure S8B), con-
firming that activation of the Wnt pathway leads to increased
differentiation of human DCs. Thus, in both mice and humans
activation of the Wnt pathway promoted DC differentiation,
whereas its inhibition resulted in repression of DC differentiation
and accumulation of IMC. Taken together, these data indicated
that b-catenin was required for DC differentiation.
Cooperation between Notch and Wnt Signaling
in Differentiation of DCs
ESCs lacking Notch-1 have impaired ability to differentiate into
DCs (Cheng et al., 2003). We asked whether activation of Wntsignaling can overcome that defect. To address this question,
we used a previously described experimental system in which
DCs were generated from ESCs (Cheng et al., 2003). We
observed that differentiation of DCs from Notch1/ ESCs was
significantly reduced and the proportion of IMC was significantly
increased (p < 0.05) consistent with previous observations
(Cheng et al., 2003). Wnt signaling was activated with
SB216763 at the late-postembryonic body stage of DC differen-
tiation from ESCs (to avoid toxicity of the compound). This may
explain the fact that in Notch+/+ wild-type cells, it did not lead
to an increase in the proportion of CD11c+ DCs (Figures 4A
and 4B). However, activation of Wnt signaling restored the
proportion of DCs generated from Notch1/ ESCs to the
amount seen in wild-type ESCs and decreased the presence
of IMC (Figures 4A and 4B). These data suggested that during
regulation of DC differentiation, Wnt signaling is downstream of
Notch.
To confirm these observations, we used an alternative exper-
imental system in which HPCs were cultured with Delta-1 immo-
bilized on plastic. In this system, Delta-1 significantly (p < 0.01)
increased differentiation of DCs from enriched bone marrow
HPCs (Figures 4C and 4D). To verify that the Delta-1 effect on
DC differentiation was mediated via Notch signaling, we trans-
fected HPCs with either control or CBF-1 shRNA and then
placed them on plastic coated with Delta-1-IgG. Delta-1 induced
a significant (p < 0.05) increase in the proportion of DCs differen-
tiated from HPCs. This effect was absent when HPCs were
transfected with CBF-1 shRNA (Figure S9). In a different experi-
mental system, Notch signaling in HPCs was blocked with
g-secretase inhibitor XII (GSI). This GSI prevents proteolytic
cleavage of Notch receptors after their binding to ligands and
thus prevents release of intracellular Notch and activation of
the Notch pathway (Nefedova et al., 2008). GSI abrogated the
effect of Delta-1 on DC differentiation (Figure 4C–4E). However,
if GSI was added to the cells cultured together with Wnt3a or
SB216763, the proportion of DCs increased to the degree
observed in cells cultured on Delta-1 without GSI (Figures 4C
and 4E). These data were consistent with results of experiments
with ESCs and indicate that Wnt pathway is downstream of
Notch signaling in DC differentiation.
To establish the role of Wnt signaling in the Delta-1-mediated
effects on DC differentiation, we inhibited the Wnt pathway in
HPCs by using b-catenin shRNA. Enriched bone marrow HPCs
were transfected with control GFP or a b-catenin shRNA-GFP
plasmid and then placed on a monolayer of Delta-1-expressing
fibroblasts. Cells were cultured with GM-CSF for 5 days. Consis-
tent with previous results, Delta-1 cells substantially enhanced
DC differentiation. Inhibition of b-catenin completely abrogated
this effect (Figures 5A and 5B). To confirm these observations,
we used an alternative experimental system in which HPCs(E–H) Lin c-kit+ myeloid progenitor cells were sorted from bone marrow of b-catenin (flox+) and wild-type b-catenin (flox) mice. Cells were then infected with
either control retrovirus or retrovirus containing a Cre construct and cultured with a cocktail of cytokines for mature myeloid cell generation.
(E) The level of b-catenin in transduced cells was evaluated 3 days after infection with qRT-PCR or immunoblotting (inset).
(F) The proportion of DCs was evaluated by flow cytometry in myeloid progenitors 5 days after infection with Cre-retrovirus. Mean ± SE are shown.
(G) Allogeneic MLR. Cells 5 days after Cre-retrovirus were cocultured with T cells isolated from allogeneic BALB/c mice for 4 days in different ratios. Cell prolif-
eration was measured in triplicate by [3H]-thymidine uptake. Values are the mean ± SE.
(H) Myeloid progenitor cells (2 3 104 b-cateninflox+, CD45.2+ cells) infected with control or Cre retroviruses were transferred into lethally irradiated congenic
(CD45.1+) mice together with 106 syngenic (CD45.1+) bone marrow cells. Cells were evaluated in spleens 3 weeks later. CD45.2+CD45.1 donor cells were gated
and the phenotype was evaluated by flow cytometry.
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(A and B) DCs were differentiated fromwild-type (Notch1+/+) R1 ESCs andNotch1/ ESCs as described in the Experimental Procedures. Cells were treated with
10 nM SB216763 or vehicle for 5 days prior to analysis.
(A) Typical example of one experiment.
(B) Cumulative results of three performed experiments. Asterisks indicate statistically significant (p < 0.05) differences from the control. Mean ± SE are shown.
(C and D) Enriched HPCs were cultured on plates coated with control IgG or Delta-IgG with or without GSI, SB216763, or Wnt3a as indicated. Cells were har-
vested and phenotype was evaluated by flow cytometry.
(C) Typical example of one experiment.
(D) Cumulative results of three performed experiments. Asterisks indicate statistically significant differences from IgG control (p < 0.05). Mean ± SE are shown.
(E) AllogeneicMLR. Cells were cultured with T cells isolated from allogeneic BALB/cmice for 4 days at different ratios. Cell proliferation wasmeasured in triplicate
by [3H]-thymidine uptake. Values are the mean ± SE.were cultured with Delta-1 immobilized on plastic. Furthermore,
inhibition of Wnt with Wif-1 substantially reduced DC differentia-
tion induced by Delta-1 (Figure 5C). These data confirm the
important role of Wnt signaling in Delta-1-mediated upregulation
of DC differentiation.852 Immunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc.Mechanism of Delta-1 Effects on Wnt Signaling
We then set out to determine the mechanism of Delta-1-induced
upregulation of Wnt signaling. First, we investigated whether this
effect is dependent on Notch signaling. Notch signaling in HPCs
was blocked with GSI, and we confirmed inhibition of the Notch
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(A and B) Enriched HPCs were transfected with b-catenin-shRNA-GFP construct or GFP vector, and then cultured on a monolayer of fibroblasts expressing
Delta-1 or control vector (EF) for 5 days in CCM with 20 ng/ml GM-CSF. Cells were labeled with a cocktail of indicated antibodies and evaluated by flow
cytometry. CD45+GFP+ cells were gated and the proportion of DCs or IMC was analyzed within this group of cells.
(A) Typical example of one experiment.
(B) Cumulative results of three performed experiments. Asterisks indicate statistically significant differences from the EF control (p < 0.05). Mean ± SE are shown.
(C) HPCs were incubated in CCM supplemented with 20 ng/ml GM-CSF for 5 days on a 24-well plate coated with Delta-1 protein or control IgG. Wif1 (750 ng/ml)
was added at the start of the culture. Cell phenotype was evaluated by flow cytometry. The left side shows a typical example of one experiment. On the right are
accumulative results of three performed experiments. Asterisks indicate statistically significant differences from the IgG control (p < 0.05). Mean ± SE are shown.pathway by measuring expression of the Notch-targeted genes
Hes5 and Hes1 (Figure 6A). Treatment of HPCs with GSI
completely abrogated the effect of immobilized Delta-1 on the
expression of mouse Frizzled genes (mFzd) and its associated
activation of the Wnt pathway (Figure 6A). To verify the role of
RBP-Jk (CBF-1, the main transcription factor involved in Notch
signaling) in the regulation of the Wnt pathway, we blocked
CBF-1 expression in the 32D murine hematopoietic cells line
by using siRNA. Inhibition of CBF-1 resulted in a dramatic down-
regulation of mFzd gene expression and the Wnt-pathway-tar-
geted genes Axin2, Wisp1, and Wisp2 but not a Tcf1 gene (Fig-
ure 6B). To investigate the specific role of Notch-1 in regulation
of Fzd gene expression and Wnt signaling, we used ESCs with
a targeted deletion of the Notch1 gene (Cheng et al., 2003).
Notch1-deficient ESCs had a dramatically reduced expression
of the Notch-targeted gene Hes5. In the absence of Notch1,expression of Fzd- and Wnt-targeted genes was significantly
(p < 0.01) reduced (Figure 6C).
Promoter regions of all mFzd genes contain multiple RBP-Jk
binding sites (Table S1). To test the ability of this transcription
factor to bind to the Fzd promoter, we selected Fzd10 as one
representative member of the Frizzled family. A ChIP assay
was performed targeting a 3 kb sequence upstream of the
Fzd10 gene transcription initiation site. Five different sets of
primers spanning potential CBF-1 binding sites were used. As
a positive control, we used primers that amplify the promoter
region of Hes1. Anti-CBF-1 immunoprecipitated DNA that was
amplified by primers specific for Hes1, as well as with four out
of the five sets of primers specific for Fzd10. No amplification
was detected when control IgG was used for immunoprecipita-
tion (Figure 6D). For verifying the regulation of the Wnt pathway
by Notch-1, 32D cells were transfected with a constitutivelyImmunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc. 853
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of Wnt Receptors via Notch Signaling
(A) Enriched HPCs were cultured in wells of a
24-well plate coated with Delta-IgG or control IgG
with or without GSI (5 nM) for 24 hr. Expression of
Fzd receptors and Wnt-targeted genes were eval-
uated in quadruplicates by qRT-PCR. Hes5 and
Hes1 were used as a positive control. Mean ± SE
are shown.
(B) 32D cells were transfected with a control
nontarget pool of siRNAs or CBF-1 siRNA. Inhibi-
tion of CBF1 expression was confirmed by
immunoblotting 48 hr after transfection (inset).
Expression of Fzd and Wnt-targeted genes
was measured in quadruplicates by qRT-PCR.
Mean ± SE are shown.
(C)We used qRT-PCR to determine the expression
of Fzd and Wnt-targeted genes in wild-type or
Notch-1-deficient ESCs. In (A)–(C), mean ± SE
from three experiments are shown.
(D) ChIP assay was performed in 32D cells with
antibodies against CBF-1 or control IgG as
described in the Experimental Procedures. Re-
cruitment of potential CBF-1 binding sites within
the Fzd10 promoter by CBF-1 protein was evalu-
ated by qPCR and presented as the fold increase
over input DNA. Two experiments with the same
results were performed.
(E) HPCs were transduced with GFP or Notch-IC-
GFP vectors and cultured in complete medium
containing 20 ng/ml GM-CSF for 24 hr. GPF-posi-
tive cells were sorted and the expression of Fzd
andWnt-targeted genes was evaluated in quadru-
plicates by qRT-PCR. Two experiments with the
same results were performed.
(F) HPCs were cultured in wells of a 24-well plate
coated with 7.5 mg/ml control IgG or Delta-1 with
or without Wnt inhibitor WIF-1 (750 ng/ml) for
24 hr. Expression of Wnt-targeted genes was
measured in quadruplicates by qRT-PCR. Fold
increase over the background (gene expression
in HPC cultured with control IgG) is shown.active Notch-1(NIC)-GFP construct (Cheng et al., 2007). As
a control, we used a vector containing only GFP. GFP-positive
cells were sorted and gene expression was evaluated by qRT-
PCR. Overexpression of Notch-1 resulted in a significant
(p < 0.01) upregulation of Fzd6 and Fzd10 expression as well
as several Wnt-targeted genes (Figure 6E). Collectively, these
data indicate that Delta-1-induced upregulation ofWnt receptors
and activation of Wnt signaling is mediated by the RBP-Jk
transcription factor via activation of the Notch pathway.
To verify the role of Wnt receptors in Delta-1-mediated activa-
tion of Wnt signaling, we cultured HPCs with Delta-1-expressing
fibroblasts in the presence ofWif-1, an antagonist that bindsWnt
protein and prevent its interaction with the receptors (He et al.,
2005; Hsieh et al., 1999). If Delta-1 affects the Wnt pathway
downstream of the receptors, then blockade of extracellular
Wnt interacting with its receptors would have a very limited
effect on Wnt signaling. The presence of Wif-1 in culture
medium, however, dramatically reduced the effect of Delta-1
on activation of the Wnt pathway (Figure 6F). Taken together,
these results indicated that Notch signaling directly regulated
expression of Fzd.Spleen Stroma Activates Wnt Signaling Leading to DC
Differentiation
Wehave previously shown that spleen stroma (SS) promoted DC
differentiation, whereas BMS promoted accumulation of imma-
ture DC precursors. We also demonstrated that this effect was
associated with different amounts of Delta-1 in these cells.
Expression of Delta-1 on SS was much higher than that in
BMS (Cheng et al., 2007). To investigate a potential effect of
different stroma onWnt signaling in HPCs, we prepared amono-
layer of BMS and SS and cultured HPCs on top of these cells for
48 hr with GM-CSF. Expression of Fzd genes, Wnt-pathway-
targeted genes (Figure 7A), and b-catenin (Figure 7B) and
TCF-LEF transcriptional activity (Figure 7C) were significantly
(p < 0.05) higher in HPCs cultured on SS than on BMS. To eval-
uate the possible effects of BMS and SS on Wnt signaling in
HPCs in vivo, we isolated enriched HPCs from bone marrow of
C57BL/6 (CD45.2+) mice, and 106 cells were transferred intrave-
nously (i.v.) into irradiated congenic (CD45.1+) recipients. Thirty-
six hours after transfer, donor CD45.2+ cells were isolated from
spleens and bone marrow and RNA was extracted. HPCs
prior to transfer served as a background control. During this
Immunity
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Stroma on Wnt Signaling in HPCs
(A–C) BMS and SS were generated from naive
CD45.2+ mice and enriched HPCs from CD45.1+
congenic mice were cultured on a BMS or SS
monolayer for 18 hr.
(A) Eighteen hours after coculture, CD45.1+ cells
were isolated and expression of Fzd and Wnt-
targeted genes was measured in triplicates by
qRT-PCR. Mean ± SE from three independent
experiments are shown.
(B) The level of b-catenin was measured by immu-
noblotting after 5 days of culture. Relative intensity
of bands was normalized to b-actin and is shown
in the bottom panel.
(C) HPCs were transfected with TCF-LEF reporter
plasmid before culture on a BMS or SS monolayer
for 48 hr. Luciferase activity was measured as
described in the Experimental Procedures. Each
measurement was performed in duplicate and
the results of three independent experiments are
shown.
(D) Naive C57BL/6 recipient mice were irradiated
and injected intravenously with 1.53 106 enriched
HPCs from CD45.1+ congenic mice. Spleen and
bone marrow were harvested 36 hr after injection
and CD45.1+ cells were isolated with magnetic
beads. Expression of Wnt-targeted genes was
evaluated in quadruplicates by qRT-PCR. Values
are the mean ± SE from two mice.
(E)Spleenstromacellswere transfectedwithDelta-
1 siRNA or control nontarget pool siRNA. Inhibition
of Delta-1 expression was confirmed by immuno-
blotting (inset) 48 hr after transfection. Expression
of Fzd andWnt-targeted genes in HPCswas evalu-
ated by qRT-PCR. Each measurement was per-
formed in triplicate and the results (mean ± SE)
of three independent experiments are shown.procedure, we typically recovered 1.3 to 1.5 3 104 donor cells
from bone marrow and 0.9 to 1.1 3 104 donor cells from the
spleen. Donor cells isolated from the spleen demonstrated an
increase in the expression of Fzd6 and Fzd10 as well as Wnt
pathway-targeted genes, whereas only slight changes were
observed in cells isolated from bone marrow (Figure 7D). These
data were consistent with in vitro observations of the effects of
Delta-1 on Wnt signaling. To verify the potential role of Delta-1
in the SS effect on Wnt signaling in HPCs, we transfected SS
cells with Delta-1 siRNA. HPCs cultured on a monolayer of SS
with a reduced level of Delta-1 demonstrated a substantially
lower expression of Wnt receptors and Wnt-targeted genes
than HPCs cultured on SS transfected with control nontarget
pools of siRNAs (Figure 7E). Taken together, these results indi-
cated that SS and BMS differently regulated expression of Fzd
genes and activation of Wnt pathway. Spleen stroma induced
much stronger activation of Wnt pathway than BMS.
DISCUSSION
Our results demonstrate the existence of a close cooperation
between Notch and Wnt pathways in the regulation of DC differ-
entiation.Notch signalingwaspreviously implicated in the regula-
tion of DC differentiation. However, reported results are contro-
versial. On one hand, a number of groups primarily using ‘‘gainof function’’ experiments, in which Notch signaling was activated
by Delta-1, demonstrated the induction of differentiation of
conventional DCs (Caton et al., 2007; Cheng et al., 2003; Cheng
et al., 2001; Hoshino et al., 2005; Mizutani et al., 2000; Ohishi
et al., 2001). On the other hand, a number of studies primarily
utilizing experiments with ‘‘loss of function’’ based on gene-tar-
geted approach showed either that Notch signaling did not
have an effect or that it inhibited DC development (De Smedt
et al., 2005; Feyerabend et al., 2009; Garcia-Peydro et al., 2006;
Radtke et al., 2000). Similar contradictory data exist in respect
to theeffect ofNotchsignalingonpDCs (Catonet al., 2007;Dontje
et al., 2006; Ferrero et al., 2002; Olivier et al., 2006; Radtke et al.,
2000). Our study may help to resolve some of those contradic-
tions and clarify the role of Notch signaling in DC differentiation.
We have shown that Delta-1 may exert its effect on DC differ-
entiation primarily via activation of the Wnt pathway. Our results
demonstrate a critical role of the canonical Wnt pathway for
differentiation of myeloid DCs. DC differentiation from HPCs
was associated with gradual activation of the Wnt pathway.
Downregulation of b-catenin in HPCs inhibited DC differentia-
tion, whereas degradation-resistant b-catenin promoted DC
differentiation. Similar results were obtained when Wnt signaling
was activated byWnt3a or inhibition of GSK3b. Importantly, acti-
vation of the Wnt pathway had the opposite effect on pDCs and
did not affect differentiation of macrophages.859, June 19, 2009 ª2009 Elsevier Inc. 855
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disruption of E-cadherin-mediated interactions between DCs
and adjacent cells increase the amount of b-catenin in the
cytoplasm. E-cadherin disruption resulted in the phenotypic
maturation of DCs, as shown by the increased expression of
costimulatory molecules, MHC class II molecules, and chemo-
kine receptors (Jiang et al., 2007). It is important to point out
that our study did not address the role of b-catenin and Wnt
signaling in DC function. It is possible that regulation of the
Wnt pathway in DCs may affect the ability of these cells to stim-
ulate immune responses. Recent information that DC-specific
stabilization of b-catenin in mice prevented the efficient genera-
tion of antigen-specific immune responses (Staal et al., 2008)
might support such a possibility.
Wnt proteins are produced by many types of cells including
HPCs, stroma, and macrophages. (Blumenthal et al., 2006;
Lobov et al., 2005). During DC differentiation in vitro or in vivo,
therefore, HPCs are constantly in contact with ligands. This
may explain the fact that blockade of Wnt signaling affects DC
differentiation even without presence of stroma cells. It appears
that Notch ligands may affect Wnt signaling in HPCs by regu-
lating the level of expression of the Frizzled family of Wnt recep-
tors. Several lines of evidence have demonstrated that Delta-1
regulates the expression of Frizzled via activation of the Notch
pathway: inhibition of Notch pathways with either GSI or down-
regulation of CBF-1 resulted in abrogation of a Delta-1 effect on
the Wnt pathway; Notch-1-deficient ESCs had substantially
reduced expression of Fzd and Wnt-targeted genes; there is
a direct physical interaction between CBF-1 and the promoter
of Fzd10; constitutively active Notch-1 directly upregulated Fzd
expression.
Our data suggest that Delta-1 activates Wnt signaling in HPCs
primarily via upregulation of Frizzled receptors. Delta-1 upregu-
lated expression of at least eight different members of Frizzled
family. Because of functional overlap between them, ablation
of individual receptors would not help to clarify their role in
Delta-1-mediated activation of Wnt signaling. Stroma cells and
HPCs also express different members of the Wnt family. There-
fore, we blocked Wnt ligands with the soluble inhibitor Wif-1 and
observed abrogation of Delta-1-mediated activation of Wnt
signaling. We argue that if Delta-1 targeted downstream mole-
cules in the Wnt pathway, Wif-1 should have a minimal effect
on Wnt signaling.
Our data indicate that the Notch-Wnt axis may have a specific
role in regulation of DC but not macrophage differentiation.
These data are in agreement with observations from one group
that conditional deletion of b-catenin in HPCs resulted in normal
development of granulocytes and macrophages (Cobas et al.,
2004; Koch et al., 2008). However, it remains to be seen whether
DC differentiation is affected in those cells and whether our data
on specific regulation of DCs by Notch-Wnt pathways could be
reproduced in different experimental systems. Our data suggest
that the canonical and noncanonical pathways of Wnt signaling
have opposite effect on DC differentiation. Activation of the non-
canonical pathway with Wnt5a in contrast to canonical pathway
resulted in inhibition of DC differentiation. It has been previously
demonstrated that there is competition between noncanonical
and canonical Wnt pathways. Noncanonical Wnt ligands can
inhibit canonical Wnt signaling in transformed cell lines and in856 Immunity 30, 845–859, June 19, 2009 ª2009 Elsevier Inc.Xenopus and mouse embryos. It was also reported that Wnt5a
treatment could inhibit canonical Wnt signaling in hematopoietic
stem cells (Malhotra and Kincade, 2009). Wnt5a has been shown
to antagonize Wnt3a signals via GSK-3-independent b-catenin
degradation (Topol et al., 2003). Other potential mechanisms
for the noncanonical Wnt-mediated inhibition of canonical path-
ways would involve competition for molecules like Dishevelled
that are shared by the two pathways.
The presented data provide a new model of regulation of DC
differentiation in various tissue compartments. Notch ligands
expressed on adjacent stroma cells induce upregulation of
members of the Frizzled family of Wnt receptors in HPCs.
Because Wnt ligands are produced by stroma cells, this results
in activation of the Wnt pathway and differentiation of DCs.
Thus, DC differentiation is regulated by the amount of available
Wnt proteins and by the amount of Notch ligand expressed on
adjacent cells. Our data suggest that the Wnt pathway can be
downstream of Notch in the regulation of DC differentiation.
This model may also explain the discrepancy in reports of Notch
effects on DCs. Activation of the Notch pathway by itself is not
sufficient for DC differentiation and requires Wnt, the amount
of which depends on the presence and the nature of the
surrounding stromal cells. On the other hand, activation of the
Wnt pathway may overcome the absence of Notch signaling.
This may explain the normal number of DCs in Notch-gene-
targeted mice reported previously (Radtke et al., 2000; Radtke
et al., 1999). This cooperation between Notch and Wnt signaling
may provide a DC system with the flexibility it needs to




All mouse experiments were approved by the University of South Florida Insti-
tutional Animal Care and Use Committee. Female C57BL/6 mice (aged 6–8
weeks) were obtained from the National Cancer Institute. b-cateninflox+ mice
(mouse strain #004152) and CD45.1+ congenic mice (B6.SJL-PtrcaPep3b/
BoyJ) were purchased from Jackson Laboratories. Detailed description of
reagents used in the study is provided in the Supplemental Experimental
Procedures.
Cell Lines, HPC-3T3 Coculture, and Flow Cytometric Analysis
The NIH 3T3 cell lines transfected with Delta-1 or control plasmid were
described previously (Cheng et al., 2007). Confluent fibroblasts were cultured
overnight in DMEM with 10% FBS. Mouse HPCs from mouse bone marrow
were enriched with a lineage cell depletion kit from Miltenyi Biotec (Auburn,
CA, USA). Enriched HPC cells from naive bone marrow were placed onto
3T3 cells the following day and cultured in RPMI medium supplemented with
10% FBS and 20 ng/ml GM-CSF for various time periods. HPCs were trans-
ferred to new wells of coated with corresponding 3T3 cells every 2–3 days.
Cell phenotypewas analyzed by flow cytometry on a FACSCalibur flow cytom-
eter (BD Biosciences, Mountain View, CA, USA), and data were analyzed with
the CellQuest program (Becton Dickinson, Mountain View, CA, USA). CD45+
cells were gated so that hematopoietic cells could be distinguished from
contaminated stroma. For the analysis of gene and protein expression, hema-
topoietic cells were isolated with biotin-conjugated CD45 antibody and
magnetic beads (Miltenyi Biotec). 32D cells (murine hematopoietic cells line)
were cultured in RPMI medium with 10% FBS and 20% conditioned medium
containing IL-3 (WEHI-3B cell line).
Immobilization of Notch ligands on plastic was performed as described
previously (Ohishi et al., 2000). In brief, 20 mg/ml of antibody against human
IgG was placed into each well of a 24-well plate and incubated for 30 min at
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37C with 7.5 mg/ml Delta-1 or IgG in CCM.
Differentiation of Human DCs
After obtaining informed consent, bone marrow cells were collected from
disposed filters used for bone marrow transplantation. CD34+ cells were iso-
lated with magnetic beads (Miltenyi Biotec) and cultured in complete culture
medium supplemented with 100 ng/ml hGM-CSF, 25 ng/ml hSCF, and
2.5 ng/ml TNFa for 6 days. Ten nM SB216763 or 750 ng/ml recombinant
human Wif-1 were added at the start of the cultures.
Quantitative Real-Time Polymerase Chain Reaction
and Immunoblotting
RNA was extracted with an RNase Mini kit and cDNA was synthesized with
a SuperScript III Reverse Transcriptase kit (QIAGEN, Valencia, CA, USA).
PCR was performed as described earlier (Nefedova et al., 2004) with 2.5 ml
cDNA, 12.5 ml SYBR Master Mixture (Applied Biosystems, Foster City, CA,
USA), and target gene-specific primers (Table S2). Amplification of endoge-
nous cyclophilin was used as an internal control. The analysis of gene expres-
sion by immunoblotting was performed as previously described (Cheng et al.,
2007). Cell lysate was subjected to electrophoresis in 8% sodium dodecyl
sulfate-polyacrylamide gels; this was followed by transfer to a polyvinylidene
difluoride membrane and probing with specific antibodies. Equal loading
was determined by b-actin levels. The specific bands were visualized by an
enhanced chemiluminescence (ECL) detection kit (Amersham Life Sciences,
Arlington Heights, IL, USA).
HPC Cell Transfection and Luciferase Reporter Assay
HPCs were transfected with mouse macrophage buffer and Y01 program at
AMAXA nucleofector (AMAXA, Gaithersburg, MD, USA). GFP-positive cells
were gated for further analysis by flow cytometry or sorted with a FACSAria
cell sorter. Transfection efficacy was 5%–10% (Figure S4). For the reporter
activity assay, enriched HPCs were transfected with either TCF/LEF or
CBF-1 reporter plasmids (a mixture of inducible TCF/LEF or CBF-1 responsive
firefly luciferase and Renilla luciferase constructs) from SABiosciences
(Frederick, MD, USA). Relative light units (RLUs) of luminescence were
measured 48 hr after transfection with a dual-luciferase reporter assay system
(Promega, Madison, WI, USA).
Bone Marrow Stroma and Spleen Stroma Culture
Bone marrow stroma and spleen stroma cells were generated as described
previously (Cheng et al., 2007).
Embryonic Stem Cell Culture
Differentiation of DCs from ESCs was performed as described earlier (Cheng
et al., 2003). In brief, ESCs were grown on gelatinized plates for 3 days and
transferred to bacterial-grade Petri dishes without leukocyte inhibitory factor
to induce formation of embryonic bodies. Two weeks later, individual bodies
were picked and transferred to a 24-well plate with 20 ng/mL GM-CSF and
10 ng/mL IL-3 and cultured for 14 days. DC cells were plated in a new
24-well plate and treated with SB216763 for 5 days before analysis.
Chromatin Immunoprecipitation Assay
ChIP assay was performed with the reagents and protocol from Millipore (Bill-
erica, MA, USA). In brief, we fixed 2 3 106 32D cells by adding formaldehyde
into culture media to a final concentration of 1%. Cells were then lysed and
sonicated to shear the chromatin DNA. Cell lysate was precleared with protein
G-agarose before immunoprecipitation overnight at 4C with 2 mg of CBF1
antibody or normal mouse IgG. The precipitated antibody-chromatin complex
was collected by incubation with protein G-agarose for 1 hr at 4C and subse-
quently washed and eluted in elution buffer. DNA in the precipitated samples
was recovered after reverse crosslinkage at 65C for 4 hr. Ten percent of lysate
before antibody precipitation was used as the input. Real-time PCR was
carried out with Fzd10-specific primers encompassing each of the potential
CBF1 binding sites. Hes1-specific primers that encompassed the CBF1
binding site were used as a positive control. Amplification of cyclophilin from
the input was used as the loading control.DC Differentiation from HSCs and CMPs
HSCs (Linc-kit+Sca-1+CD34) and CMPs (Linc-kit+Sca-1CD34+) were
sorted from mouse bone marrow. We then culture cells in myeloid long-term
culture medium with a cocktail of cytokines (20 ng/ml of IL-3, IL-11, SCF,
Flt3L, and GM-CSF) for 5 days and cultured them for another 5 days in
RPMI-1640 medium supplemented with GM-CSF in the presence of
SB216763, Wnt3a, or Wnt5a to induce DC differentiation.
Adoptive Cell Transfer
Naive C57BL/6 (CD45.2+) recipient mice were irridiated (500 Rad, twice with
a 3 hr interval) and 1.5 3 106 isolated HPCs from CD45.1+ congenic mice
were then injected intravenously (i.v.). Spleen and bonemarrow cells were har-
vested 36 hr after injection and CD45.1+ cells were sorted with a FACSAria.
Allogeneic Mixed Leukocyte Reaction
HPCswere isolated from bonemarrow of naive C57BL/6mice and were cocul-
tured with T cells (105/well) from allogeneic BALB/c mice for 4 days in triplicate
inU-bottom96-well plates at different ratios. [3H]-thymidine (1mCi [0.037MBq])
was added to each well 18 hr prior to cell harvest. T cell proliferation was
measured by [3H]-thymidine incorporation with a liquid scintillation counter
(Packard Instrument,Meriden, CT, USA). For the humanmixed leukocyte reac-
tion assay, cells differentiated fromdonorCD34+cellswere culturedwith T cells
isolated from peripheral blood of a different healthy donor for 5 days. T cell
proliferation was then measured by [3H]-thymidine incorporation as described
above.
Retrovirus Preparation and Infection of Myeloid Progenitor Cells
The HR-MMPCreGFP retroviral construct (Harvard Institute of Proteomics,
Massachusetts, USA) carrying an bioactive Cre-GFP fusion protein with
a lox 511 in the 30 LTR U3 region were transfected into Phoenix-Ampho cells
with GenePORTER2 (GTS, San Diego) as described by the supplier. Superna-
tants were harvested at 48 and 72 hr after transfection and concentrated by
ultracentrifugation at 16,600 rpm at 4C for 90 min. The pellet was resus-
pended overnight at 4C in 400 ml RPMI media and kept frozen at 80C.
Linc-kit+ myeloid progenitor cells were sorted from mouse bone marrow
and were cultured in myeloid long-term culture medium supplemented with
a cytokine cocktail (20 ng/ml of IL-3, IL-11, SCF, Flt3L, and GM-CSF) for
1 day. Cells were then infected with concentrated Cre- or control retrovirus
twice with a 24 hr interval as described earlier (Cheng et al., 2007). We then
used these cells for adoptive transfer into CD45.2+ congenic mice or cultured
them in 20 ng/ml GM-CSF for 5 days to induce DC differentiation.
In adoptive transfer experiments 2 3 104 CD45.2+ myeloid progenitor cells
infected with retroviruses were injected i.v. into irradiated (500 rad twice with
a 3 hr interval) CD45.1+ congeneic mice together with 106 bone marrow cells
from CD45.1+ mice. Spleens were harvested and evaluated 3 weeks after
the transfer.
Statistical Methods
Most of the data were analyzed with a two-tailed Mann-Whitney test. Where
warranted, two-tailed parametric t test was used. p values < 0.05 were consid-
ered to be statistically significant.
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